AI assistant
REPLIGEN CORP — Director's Dealing 2018
Jul 31, 2018
30826_dirs_2018-07-30_63f12dcf-d45d-4dea-b985-4b657ab893d4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2018-07-26
Reporting Person: EDDLEMAN ROY T (10% Owner)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-07-26 | Call option(obligation to sell) | $53.9372 | S | 1 | Disposed | 2019-07-26 | Common Stock (250000) | Indirect |
| 2018-07-26 | Put option (right to sell) | $43.891 | P | 1 | Acquired | 2019-07-26 | Common Stock (250000) | Indirect |
Footnotes
F1: The reporting person entered into a so-called zero-cost collar arrangement pursuant to which he wrote a covered call option and purchased a put option. Only one of the options can be "in the money" on the expiration date, at which time the in-the-money option will be exercised (or settled in cash), and the other option will expire. If neither option is in the money on the expiration date, both will expire.
F2: The securities shown are held of record by the Roy T. Eddleman Living Trust UAD 8-7-2000, of which the reporting person is the sole trustee and, as such, has investment and voting control over such securities.